15-Cyclopropyloxy-2,2-dimethyl-15-oxopentadecanoic acid

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 15-Cyclopropyloxy-2,2-dimethyl-15-oxopentadecanoic acid
• 英文别名: 15-cyclopropyloxy-2,2-dimethyl-15-oxopentadecanoic acid
• 化学式: C₂₀H₃₆O₄
• 分子量: 340.5
• InChiKey: CFXSXDIXLCYSRC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.6
• 重原子数：
  24
• 可旋转键数：
  16
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  63.6
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES AND DYSLIPIDEMIA
  申请人：Khanna Ish

  公开号：US20140121267A1

  公开（公告）日：2014-05-01

  Novel compounds of Formula A1 are provided: its stereoisomers and/or pharmaceutically acceptable salts for the treatment of diabetes and diabetes-associated dyslipidemia, wherein R 7 is independently selected from a group consisting of hydroxy, alkoxy, alkyl, amine, NHR′ wherein R′ is alkyl or cycloalkyl optionally substituted by hydroxy or alkoxy, NHSO 2 R or NHCOR, wherein R is selected from alkyl or cycloalkyl. At least one of R 3 and R 4 and/or R 5 and R 6 form a cyclic ring of 3-8 carbon atoms optionally containing alkyl groups, hetero atoms, or functional groups such as O, N, SO 2 . Additionally R 3 and R 4 or R 5 and R 6 , when they do not form a cyclic ring, are independently selected from hydrogen, alkyl, branched alkyl, and cycloalkyl. L 1 is independently a linear aliphatic chain optionally containing from 6 to 16 carbon-atoms and L 1 may optionally be substituted one or more times by alkyl, branched alkyl, cycloalkyl, or aryl.

  提供了化合物A1的新型化合物：其立体异构体和/或药学上可接受的盐，用于治疗糖尿病和糖尿病相关的血脂异常，其中R7独立地选择自羟基，烷氧基，烷基，胺基，NHR′，其中R′是烷基或环烷基，可以选择性地被羟基或烷氧基取代，NHSO2R或NHCOR，其中R选择自烷基或环烷基。 R3和R4和/或R5和R6中至少有一个形成一个由3-8个碳原子组成的环状环，可以选择性地含有烷基，杂原子或功能基团，例如O，N，SO2。此外，当它们不形成环状环时，R3和R4或R5和R6独立地选择自氢，烷基，支链烷基和环烷基。 L1是独立的线性脂肪链，可以选择性地含有6到16个碳原子，L1可以选择性地被烷基，支链烷基，环烷基或芳基取代一次或多次。